HCV is a major cause of increased morbidity and mortality in patients with chronic kidney disease (CKD). Since, HCV is transmitted through blood and blood products prevalence of anti-HCV among Hemodialysis (HD) patients is consistently higher among them. Factors such as blood transfusion and frequent parenteral interventions have been shown to be associated with increased risk of HCV infection. |